View printer-friendly version << Back
MEDNAX Expands in Jacksonville with Acquisition of Maternal-Fetal Medicine Physician Practice

FORT LAUDERDALE, Florida--(BUSINESS WIRE)--May. 26, 2009-- Driven by the need to balance patient care and growing demand for their services, a group of maternal-fetal medicine physicians based in Jacksonville, Florida, have joined MEDNAX, Inc. (NYSE: MD), a national group practice focused on neonatal, maternal-fetal, pediatric cardiology and anesthesia physician services, following the acquisition of their practice.

Regional Obstetric Consultants is a five-physician practice that also includes more than 30 clinical and administrative support staff that provides care to expectant mothers, including the management of high-risk pregnancies, throughout northeast Florida and southern Georgia. Regional Obstetric Consultants has two offices, and relationships with six hospitals in Jacksonville and the Daytona Beach, Florida, area.

The group will practice as part of MEDNAX’s Pediatrix Medical Group, a national medical group that encompasses the nation’s leading neonatal, maternal-fetal medicine and pediatric cardiology physician group practice. Neonatal physicians who practice as part of Pediatrix also staff neonatal intensive care units at three of the Jacksonville-area hospitals where Regional Obstetric Consultants’ physicians practice.

“Our practice has been clinically service-oriented for the past 20 years, and we’ve expanded in response to higher demand for our services and the growth of our community,” said Ramon Castillo, M.D., who will serve as the Medical Director of the Jacksonville maternal-fetal practice. “It’s time for us to be part of a larger, more experienced structure that will allow us to manage our growth, and gives us the opportunity to participate in a national database of maternal fetal outcomes to improve care in our community.”

MEDNAX paid cash for the practice, which is expected to be immediately accretive to the Company’s earnings. No additional terms of the transaction were disclosed. With the acquisition of Regional Obstetric Consultants, MEDNAX has completed five physician group practice acquisitions during 2009.


MEDNAX, Inc., is a national medical group that comprises the nation’s leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 250 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation’s largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 450 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,275 physicians in 32 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements which may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors,” as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

Bob Kneeley, 954-384-0175, ext. 5300
Director, Investor Relations